The cyclin-dependent kinase inhibitor flavopiridol inhibits glycogen phosphorylase and affects glucose metabolism.

被引：0
|
作者：
Kaiser, AU
Nishi, K
Walsh, DA
Gorin, FA
Bradbury, EM
Schnier, JB
机构：
[1] Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：3754S / 3754S
页数：1
相关论文
共 50 条
  • [21] Inhibition of cyclin-dependent kinase I (CDC2) by ethanol metabolism.
    Clemens, DL
    Sorrell, MF
    Tuma, DJ
    HEPATOLOGY, 2002, 36 (04) : 446A - 446A
  • [22] Flavopiridol as cyclin dependent kinase (CDK) inhibitor: a review
    Deep, Aakash
    Marwaha, Rakesh Kumar
    Marwaha, Minakshi Gupta
    Jyoti
    Nandal, Rimmy
    Sharma, Arun Kumar
    NEW JOURNAL OF CHEMISTRY, 2018, 42 (23) : 18500 - 18507
  • [23] Pharmacodynamic assessment of the cyclin-dependent kinase inhibitor flavopiridol: Modulation of cdk targets in clinical samples
    Di Vizio, D
    O'Connell, FP
    Bhattacharya, N
    Shapiro, GI
    Loda, M
    MODERN PATHOLOGY, 2005, 18 : 297A - 297A
  • [24] Regulation of yeast glycogen phosphorylase by the cyclin-dependent protein kinase Pho85p
    Wilson, WA
    Wang, Z
    Roach, PJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) : 161 - 167
  • [25] Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells
    Motwani, M
    Li, XK
    Schwartz, GK
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 924 - 932
  • [26] Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol
    Nelson, PJ
    D'Agati, VD
    Gries, JM
    Suarez, JR
    Gelman, IH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 921 - 929
  • [27] Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
    Saisomboon, Saowaluk
    Kariya, Ryusho
    Vaeteewoottacharn, Kulthida
    Wongkham, Sopit
    Sawanyawisuth, Kanlayanee
    Okada, Seiji
    HELIYON, 2019, 5 (05)
  • [28] Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
    Hassan, Md Sazzad
    Cwidak, Nicholas
    Johnson, Chloe
    Daester, Silvio
    Eppenberger-Castori, Serenella
    Awasthi, Niranjan
    Li, Jun
    Schwarz, Margaret A.
    von Holzen, Urs
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma
    Schwartz, GK
    Ilson, D
    Saltz, L
    O'Reilly, E
    Tong, W
    Maslak, P
    Werner, J
    Perkins, P
    Stoltz, M
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 1985 - 1992
  • [30] Plant cyclin-dependent kinase inhibitor gene
    Wang, H.
    Fowke, L.C.
    Crosby, W.L.
    Nature, 1997, 386 (6624):
12345